Australia's largest stock trading and investment forum Australia's #1 stock forum

AGN

Click for more information

1.47%

69.0¢ argenica therapeutics limited

I tend to agree with you, we will see the trial accelerate after...

First 17 Last

Share
Profile

Follow
whitepointer

1,191 Posts.

122

24/07/24

16:35

Post #: 74897636
Share

Originally posted by alphabette: ↑

I expect the trial to complete the dosing of all 92 patients many months before the recruitment target of the end of calendar year 2025.

In round figures to date there's been 20 patients dosed in 4 months in 5 hospitals. (Being overly generous here, there hasn't been all 5 hospitals dosing for the full 4 months) But to keep it simple let's just say 5 patients dosed per month.

Extrapolating, with all 10 hospitals recruiting = 10 patients per month. (Again, super conservative imo).

We require another ~70 patients enrolled to complete the trial, so +7 months @ 10 patients per month brings us to around end of February early March 2025.

Very obviously not an exact science and there's all sorts of variables at play, including how long the new hospitals sites take to start recruiting, but people claiming delays in the trial etc did not read the latest announcement stating the trial is in fact ahead of schedule.

Expand

I tend to agree with you, we will see the trial accelerate after the safety protocols are assessed and approved after current 23 patients are dosed.

Also, the two Western Australian hospitals Fiona Stanley and Sir Charles Gairdner are now dosing and AGN is based and well known in the local health system.

AGN Price at posting: 80.0¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

LU7

The Breakdown: Lithium Universe talks financial modelling and lithium pricing in strong preliminary feasibility study for Bécancour

BC8

Black Cat Syndicate turns producer as first gold doré poured from 100% owned Myhree project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 17 more messages in this thread...

First 17 Last

Add AGN (ASX) to my watchlist

(20min delay)
Last 69.0¢		Change 0.010(1.47%)		Mkt cap ! $88.38M

Open	High	Low	Value	Volume
68.0¢	70.0¢	68.0¢	$26.75K	38.95K

Buyers (Bids)

No.	Vol.	Price($)
1	12480	69.0¢

Sellers (Offers)

Price($)	Vol.	No.
71.0¢	1499	1

View Market Depth

No.	Vol.	Price($)
1	10000	0.685
1	750	0.670
1	1052	0.665
3	27000	0.660
4	30452	0.650

Price($)	Vol.	No.
0.725	1373	1
0.770	26000	1
0.800	15000	1
0.830	52230	1
0.835	5000	1

Last trade - 16.10pm 03/10/2024 (20 minute delay)

AGN (ASX) Chart